Jatenzo — Blue Cross Blue Shield Of Illinois
12 indications indexed for this drug.
- Breast CancerView coverage criteria
- Breast Cancer Inoperable Metastatic Or Hormone Responsive TuView coverage criteria
- Delayed Puberty In An AdolescentView coverage criteria
- Endometriosis Amenable To Hormone ManagementView coverage criteria
- Gender Dysphoria Gender IncongruenceView coverage criteria
- Myelofibrosis Associated AnemiaView coverage criteria
- Other Androgenic Or Anabolic IndicationsView coverage criteria
- Prevention Of Attacks Of Hereditary AngioedemaView coverage criteria
- Primary HypogonadismView coverage criteria
- Secondary HypogonadismView coverage criteria
- Secondary Hypogonadotropic HypogonadismView coverage criteria
- Sex Hormone Treatment For Gender Dysphoria Gender IncongruenView coverage criteria